/LVAC

LVAC Stock - LAVA Medtech Acquisition Corp.

Q: What is the analyst price target for LVAC?

Analyst price target information is not currently available for LVAC.

Q: What is LVAC's market cap?

Market capitalization information is not currently available for LVAC.

Financial Services|Shell Companies|NASDAQ

$10.43+0.00%

+$0.00 (+0.00%) • May 10

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $11.47

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for LVAC

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2021

FY2022

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.00

52W High$10.85

52W Low$9.94

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2022	FY2021
Revenue	N/A	N/A
Gross Profit	N/A	N/A
Gross Margin	N/A	N/A
Operating Income	$-1,561,000	$297,460
Net Income	$4.50M	$17.97M
Net Margin	N/A	N/A
EPS	$0.31	$1.25

Company Overview

LAVA Medtech Acquisition Corp. does not have significant operations. It intends to acquire assets and businesses through a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization. The company focuses on pursuing opportunities in healthcare and healthcare-related industries. The company was incorporated in 2021 and is based in Waltham, Massachusetts. LAVA Medtech Acquisition Corp. is a subsidiary of LAVA Medtech Sponsor LP.

Earnings History & Surprises

LVAC

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$0.08

Q4 2022

EPS Surprise History

Q4 22

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q4 2022	Dec 31, 2022	—	$0.08	—	—

Frequently Asked Questions about LVAC

What is LVAC's current stock price?

LAVA Medtech Acquisition Corp. (LVAC) is currently trading at $10.43 per share. The stock has moved +0.00% today.

What is the analyst price target for LVAC?

No analyst price targets are currently available for this stock.

What sector is LAVA Medtech Acquisition Corp. in?

LAVA Medtech Acquisition Corp. operates in the Financial Services sector, specifically within the Shell Companies industry. The company is traded on the NASDAQ exchange.

What is LVAC's market cap?

LAVA Medtech Acquisition Corp. has a market capitalization of $0.15 billion, making it a small-cap company.

Does LVAC pay dividends?

No, LAVA Medtech Acquisition Corp. does not currently pay a dividend to shareholders.